Supporting the "Healthy Taiwan" Agenda: PatientsForce Wins Silver for Global Good Trailblazer of the Year in London
AI-translated from the Chinese original · editorially reviewed
TAIPEI — Private-sector biomedical innovation is playing a growing role in improving access to new medicines for patients with serious illnesses, in support of Taiwan's national "Healthy Taiwan" policy. On the evening of 24 September 2026 (UK time), at BMA House in London, Taiwanese patient support ecosystem PatientsForce received the Silver award for Global Good Trailblazer of the Year at the Global Good Awards 2026 — international recognition for Taiwan's work in patient care and health equity.
As biomedical science advances, many new cancer and rare-disease medicines carry high prices. Until they are fully reimbursed by National Health Insurance, the cost can place heavy financial pressure on patients' families. PatientsForce connects pharmaceutical companies, healthcare providers and patients to build a complete case-management care chain that supports Taiwan's national healthcare network.
Digital platform plus professional nursing: a one-stop Patient Support Program
PatientsForce works with more than 50 domestic and international pharmaceutical companies, which fund its operations, to deliver Patient Support Programs (PSPs). Its digital management platform replaces slow, paper-heavy assistance processes with a complete one-stop service:
- Simpler access to assistance and financial programs: helping patients obtain manufacturer-funded support for self-paid medicines more quickly while they wait for, or are assessed for, NHI coverage — easing the financial burden on families.
- Compliant delivery and nurse follow-up: an integrated, compliant medicine-delivery network, with dedicated nurses providing regular patient education, medication follow-up and adherence management — reducing the education workload on hospitals and clinics and helping patients get the full benefit of treatment.
From 2017 to 2025, PatientsForce served more than 30,000 patients each year and delivered a cumulative NT$10 billion in medicine subsidies, giving families facing serious illness timely help at a critical moment.
Evidence-based results recognised by international judges
The Global Good Awards hold the highest level of certification under the Awards Trust Mark and carry out in-depth, independent verification of entrants' data. PatientsForce was recognised by the international judging panel for its clear tracking data, broad service coverage and measurable contribution to improving patients' medication adherence.
Sean Chang, Chairman and President of PatientsForce, said: "As medicine becomes more personalised and precise, health equity should be advanced through market and innovation mechanisms. Digital innovation is a means to greater efficiency and lower cost, but the core goal remains improving access to innovative medicines and healthcare resources. PatientsForce hopes to be a warm bridge between government, pharmaceutical companies and patients, and to make a real difference for more families facing serious illness."
Evie Wang, Co-founder and Chief Operating Officer of PatientsForce, added: "The ultimate purpose of medical innovation is to make sure patients who need a medicine can get it and afford it. This award recognises not only the PatientsForce team, but also Taiwan's healthcare ecosystem and the strength of its private-sector care network."
Also honoured on the night was Taiwan's Tzu Chi Foundation, which received Bronze for Community Partnership of the Year — two Taiwanese organisations recognised on the international stage for their contributions to healthcare and social sustainability. PatientsForce will continue to deepen its service network across Taiwan, Hong Kong and Southeast Asia, bringing Taiwan's patient support model to more patients in Asia.
See the Global Good Awards 2026 winners. Related: Closing the Out-of-Pocket Gap in Healthcare: PatientsForce Named a 2026 Global Good Awards Finalist.
About PatientsForce
PatientsForce (Media-WIND Health Holdings) is a patient support ecosystem operating across Taiwan, Hong Kong and Southeast Asia. Through digital technology, nursing education and public–private partnership, it works with global pharmaceutical companies to deliver Patient Support Programs (PSPs) that improve access to innovative medicines and advance health equity, creating shared, sustainable value for patients, healthcare systems and the biomedical industry. Website: https://www.patientsforce.com.tw/
Media contact
PatientsForce, Media-WIND Health Holdings — PR & Marketing Olivia Chang, PR Manager olivia.chang@media-wind.com.tw
Photo: PatientsForce receives the 2026 Global Good Trailblazer of the Year Silver award. (Photo: Global Good Awards 2026, Ingrid Weel Photography)